These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 29307660

  • 1. Vitamin D receptor activation by paricalcitol and insulin resistance in CKD.
    Spoto B, Pizzini P, Cutrupi S, Tripepi G, Curatola G, Mallamaci F, Zoccali C.
    Nutr Metab Cardiovasc Dis; 2018 Mar; 28(3):291-297. PubMed ID: 29307660
    [Abstract] [Full Text] [Related]

  • 2. Serum phosphate modifies the vascular response to vitamin D receptor activation in chronic kidney disease (CKD) patients.
    Zoccali C, Torino C, Curatola G, Panuccio V, Tripepi R, Pizzini P, Versace M, Bolignano D, Cutrupi S, Ghiadoni L, Thadhani R, Tripepi G, Mallamaci F.
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):581-589. PubMed ID: 27113290
    [Abstract] [Full Text] [Related]

  • 3. Paricalcitol and endothelial function in chronic kidney disease trial.
    Zoccali C, Curatola G, Panuccio V, Tripepi R, Pizzini P, Versace M, Bolignano D, Cutrupi S, Politi R, Tripepi G, Ghiadoni L, Thadhani R, Mallamaci F.
    Hypertension; 2014 Nov; 64(5):1005-11. PubMed ID: 25259743
    [Abstract] [Full Text] [Related]

  • 4. Active vitamin D treatment in CKD patients raises serum sclerostin and this effect is modified by circulating pentosidine levels.
    Torino C, Pizzini P, Cutrupi S, Tripepi G, Mallamaci F, Thadhani R, Zoccali C.
    Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):260-266. PubMed ID: 28017524
    [Abstract] [Full Text] [Related]

  • 5. FGF23 and the PTH response to paricalcitol in chronic kidney disease.
    D'Arrigo G, Pizzini P, Cutrupi S, Tripepi R, Tripepi G, Mallamaci F, Zoccali C.
    Eur J Clin Invest; 2020 Feb; 50(2):e13196. PubMed ID: 31863599
    [Abstract] [Full Text] [Related]

  • 6. Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease.
    Thethi TK, Bajwa MA, Ghanim H, Jo C, Weir M, Goldfine AB, Umpierrez G, Desouza C, Dandona P, Fang-Hollingsworth Y, Raghavan V, Fonseca VA.
    J Diabetes Complications; 2015 Apr; 29(3):433-7. PubMed ID: 25633573
    [Abstract] [Full Text] [Related]

  • 7. Circulating adiponectin modifies the FGF23 response to vitamin D receptor activation: a post hoc analysis of a double-blind, randomized clinical trial.
    Spoto B, Pizzini P, Tripepi G, Mallamaci F, Zoccali C.
    Nephrol Dial Transplant; 2018 Oct 01; 33(10):1764-1769. PubMed ID: 29304245
    [Abstract] [Full Text] [Related]

  • 8. Vitamin D and methylarginines in chronic kidney disease (CKD).
    Torino C, Pizzini P, Cutrupi S, Tripepi R, Tripepi G, Mallamaci F, Zoccali C.
    PLoS One; 2017 Oct 01; 12(10):e0185449. PubMed ID: 28976989
    [Abstract] [Full Text] [Related]

  • 9. Paricalcitol, Microvascular and Endothelial Function in Non-Diabetic Chronic Kidney Disease: A Randomized Trial.
    Lundwall K, Jörneskog G, Jacobson SH, Spaak J.
    Am J Nephrol; 2015 Oct 01; 42(4):265-73. PubMed ID: 26496210
    [Abstract] [Full Text] [Related]

  • 10. Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic kidney disease.
    de Boer IH, Sachs M, Hoofnagle AN, Utzschneider KM, Kahn SE, Kestenbaum B, Himmelfarb J.
    Kidney Int; 2013 Feb 01; 83(2):323-30. PubMed ID: 22913981
    [Abstract] [Full Text] [Related]

  • 11. Vitamin D receptor activation raises soluble thrombomodulin levels in chronic kidney disease patients: a double blind, randomized trial.
    D'arrigo G, Pizzini P, Cutrupi S, Tripepi R, Tripepi G, Mallamaci F, Zoccali C.
    Nephrol Dial Transplant; 2019 May 01; 34(5):819-824. PubMed ID: 29668990
    [Abstract] [Full Text] [Related]

  • 12. Vitamin D receptor activation reduces inflammatory cytokines and plasma MicroRNAs in moderate chronic kidney disease - a randomized trial.
    Mansouri L, Lundwall K, Moshfegh A, Jacobson SH, Lundahl J, Spaak J.
    BMC Nephrol; 2017 May 16; 18(1):161. PubMed ID: 28511692
    [Abstract] [Full Text] [Related]

  • 13. Comparison of paricalcitol with maxacalcitol injection in Japanese hemodialysis patients with secondary hyperparathyroidism.
    Akizawa T, Akiba T, Hirakata H, Kinugasa E, Tominaga Y, Fukagawa M, Yokoyama K, Zhang W, Linde PG, Suzuki M.
    Ther Apher Dial; 2015 Jun 16; 19(3):225-34. PubMed ID: 25363733
    [Abstract] [Full Text] [Related]

  • 14. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.
    de Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, Garimella T, Parving HH, Pritchett Y, Remuzzi G, Ritz E, Andress D.
    Lancet; 2010 Nov 06; 376(9752):1543-51. PubMed ID: 21055801
    [Abstract] [Full Text] [Related]

  • 15. Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.
    Fishbane S, Chittineni H, Packman M, Dutka P, Ali N, Durie N.
    Am J Kidney Dis; 2009 Oct 06; 54(4):647-52. PubMed ID: 19596163
    [Abstract] [Full Text] [Related]

  • 16. Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients.
    Breslavsky A, Frand J, Matas Z, Boaz M, Barnea Z, Shargorodsky M.
    Clin Nutr; 2013 Dec 06; 32(6):970-5. PubMed ID: 23561637
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Relationship of insulin resistance to vitamin d status in children with nondiabetic chronic kidney disease.
    Conkar S, Mir S.
    Saudi J Kidney Dis Transpl; 2017 Dec 06; 28(5):1078-1084. PubMed ID: 28937066
    [Abstract] [Full Text] [Related]

  • 20. Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study.
    Coyne DW, Andress DL, Amdahl MJ, Ritz E, de Zeeuw D.
    Nephrol Dial Transplant; 2013 Sep 06; 28(9):2260-8. PubMed ID: 23787544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.